Balanced crystalloids are solutions designed to closely mimic human plasma, offering predictable increases in intravascular volume without altering electrolyte concentrations, unlike normal saline, which can lead to hyperchloremic metabolic acidosis. Clinical evidence suggests that balanced crystalloids reduce mortality, acute kidney injury, and complications in critically ill patients, sepsis, diabetic ketoacidosis, and postoperative recovery compared to normal saline. Guidelines recommend the use of balanced crystalloids for fluid resuscitation over normal saline due to these beneficial outcomes.